Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 14Prostatic Neoplasms 3Uterine Cervical Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2Leukemia, Myeloid, Acute 2Infertility 2Hodgkin Disease 2Endometrial Neoplasms 2Thyroid Nodule 1Thromboembolism 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Small Cell Lung Carcinoma 1Sexuality 1Sexual Dysfunction, Physiological 1Sarcoma 1Risk Malignant Index 1Renal Insufficiency, Chronic 1Recurrence 1Rectal Neoplasms 1Popliteal Cyst 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1

Interventions

High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Risk Malignant Index × High-Energy Shock Waves × Clear all
NCT03404687 2018-01-19

Risk of Malignancy Index and Assiut Scoring Model for Adnexal Malignancy

Assiut University

Completed
250 enrolled

Risk Malignant Index

Data powered by HemOnc (CC BY 4.0) Colophon âš¡